The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current Perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Froguel, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9238 · Cited by 897 · cited 1×
“Although the numbers are relatively small, a range of nonsynonomous single nucleotide polymorphisms that result in single amino acid alterations in the MC4 receptor have been reported in morbidly obese persons (Vaisse et al., 2000; Dubern et al., 2001).”
BackgroundUnbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors
Foster, L. J., de Hoog, C. L., & Mann, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631608100 · Cited by 834
Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Seifert, R., & Wenzel-Seifert, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0588-0 · Cited by 637
Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45962-5 · Cited by 589
Lee, F. J. S., Xue, S., Pei, L., Vukusic, B., Chéry, N., Wang, Y., Wang, Y. T., Niznik, H. B., Yu, X.-M., & Liu, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00962-5 · Cited by 542
Rybin, V. O., Xu, X., Lisanti, M. P., & Steinberg, S. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006951200 · Cited by 520
Specificity of short interfering RNA determined through gene expression signatures
Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D. N., & Fesik, S. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131959100 · Cited by 501
High constitutive activity of native H3 receptors regulates histamine neurons in brain
Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C. R., & Arrang, J.-M. (2000) · Nature · doi:10.1038/35048583 · Cited by 461
H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects
Leurs, R., Church, M. K., & Taglialatela, M. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.0954-7894.2002.01314.x · Cited by 450
Liu, F., Wan, Q., Pristupa, Z. B., Yu, X.-M., Wang, Y. T., & Niznik, H. B. (2000) · Nature · doi:10.1038/35002014 · Cited by 431
Yang, T.-Y., Chen, S.-C., Leach, M. W., Manfra, D., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C.-H., Narula, S. K., Chensue, S. W., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.445 · Cited by 416
Ango, F., Prézeau, L., Muller, T., Tu, J. C., Xiao, B., Worley, P. F., Pin, J. P., Bockaert, J., & Fagni, L. (2001) · Nature · doi:10.1038/35082096 · Cited by 410
AgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Nijenhuis, W. A. J. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.164 · Cited by 406
Regulators of G-Protein signalling as new central nervous system drug targets
Neubig, R. R., & Siderovski, D. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd747 · Cited by 403
Compartmentation of G Protein-Coupled Signaling Pathways in Cardiac Myocytes
Steinberg, S. F., & Brunton, L. L. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.751 · Cited by 383
Hubbell, W. L., Altenbach, C., Hubbell, C. M., & Khorana, H. G. (2003) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(03)63010-x · Cited by 352
Pleskoff, O., Tréboute, C., Brelot, A., Heveker, N., Seman, M., & Alizon, M. (1997) · Science · doi:10.1126/science.276.5320.1874 · Cited by 308
Inverse agonism: pharmacological curiosity or potential therapeutic strategy?
Milligan, G., Bond, R. A., & Lee, M. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88963-4 · Cited by 287
Self-citationGenomewide view of gene silencing by small interfering RNAs
Chi, J.-T., Chang, H. Y., Wang, N. N., Chang, D. S., Dunphy, N., & Brown, P. O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037853100 · Cited by 285
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi, M., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46876-7 · Cited by 265
Barker, E. L., Westphal, R. S., Schmidt, D., & Sanders-Bush, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32625-x · Cited by 254
Haskell-Luevano, C., & Monck, E. K. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00234-8 · Cited by 252
Yeo, G. S. H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.561 · Cited by 242
The ‘magic tail’ of G protein‐coupled receptors: an anchorage for functional protein networks
Bockaert, J., Marin, P., Dumuis, A., & Fagni, L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00453-8 · Cited by 234
Levin, M. C., Marullo, S., Muntaner, O., Andersson, B., & Magnusson, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200681200 · Cited by 231
Lessons from constitutively active mutants of G protein-coupled receptors
Parnot, C., Miserey-Lenkei, S., Bardin, S., Corvol, P., & Clauser, E. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00628-8 · Cited by 195
Dubern, B., Clément, K., Pelloux, V., Froguel, P., Girardet, J.-P., Guy-Grand, B., & Tounian, P. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116284 · Cited by 194
De Ligt, R. A. F., Kourounakis, A. P., & IJzerman, A. P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703311 · Cited by 190
Rosenkilde, M. M., Kledal, T. N., Bräuner-Osborne, H., & Schwartz, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.956 · Cited by 184
Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations
Lubrano-Berthelier, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg016 · Cited by 184
Synaptic multiprotein complexes associated with 5-HT2C receptors: a proteomic approach
Becamel, C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2332 · Cited by 173
Association between an agouti-related protein gene polymorphism and anorexia nervosa
Vink, T., Hinney, A., van Elburg, A. A., van Goozen, S. H. M., Sandkuijl, L. A., Sinke, R. J., Herpertz-Dahlmann, B.-M., Hebebrand, J., Remschmidt, H., van Engeland, H., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000854 · Cited by 173
Inverse Agonist Activity of Atypical Antipsychotic Drugs at Human 5-Hydroxytryptamine2C Receptors
Herrick-Davis, K., Grinde, E., & Teitler, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38891-3 · Cited by 173
Bécamel, C., Figge, A., Poliak, S., Dumuis, A., Peles, E., Bockaert, J., Lübbert, H., & Ullmer, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008089200 · Cited by 172
Groblewski, T., Maigret, B., Larguier, R., Lombard, C., Bonnafous, J., & Marie, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1822 · Cited by 157
Rauser, L., Savage, J. E., Meltzer, H. Y., & Roth, B. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29304-6 · Cited by 144
Mechanisms of inverse agonism at G-protein-coupled receptors
Strange, P. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01993-4 · Cited by 129
Fraile‐Ramos, A., Kohout, T. A., Waldhoer, M., & Marsh, M. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00079.x · Cited by 118
Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity
Nijenhuis, W. A. J., Garner, K. M., van Rozen, R. J., & Adan, R. A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211326200 · Cited by 115
The use of constitutively active GPCRs in drug discovery and functional genomics
Chalmers, D. T., & Behan, D. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd872 · Cited by 111
Waldhoer, M., Casarosa, P., ROSENKILDE, M. M., Smit, M. J., Leurs, R., Whistler, J. L., & Schwartz, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213179200 · Cited by 111
Miller, W. E., Houtz, D. A., Nelson, C. D., Kolattukudy, P. E., & Lefkowitz, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303219200 · Cited by 105
Adan, R. A. H., & Kas, M. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00130-5 · Cited by 101
Modulation of synaptic signalling complexes by Homer proteins
Thomas, U. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00869.x · Cited by 100
Opioid receptor random mutagenesis reveals a mechanism for G protein–coupled receptor activation
Décaillot, F. M., Befort, K., Filliol, D., Yue, S. Y., Walker, P., & Kieffer, B. L. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb950 · Cited by 97
ROSENKILDE, M. M., Waldhoer, M., Lüttichau, H. R., & Schwartz, T. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204191 · Cited by 91
Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice.
Engelhardt, S. H., Grimmer, Y., Fan, G.-H., & Lohse, M. J. (2001) · PubMed · Cited by 88
Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors
Pauwels, P. J., & Wurch, T. (1998) · Molecular Neurobiology · doi:10.1007/bf02802027 · Cited by 82
Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis
Conley, P. B., & Delaney, S. M. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200309000-00002 · Cited by 76
Miserey‐Lenkei, S., Parnot, C., Bardin, S., Corvol, P. L., & Clauser, É. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108398200 · Cited by 69
Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice
Engelhardt, S. H., Grimmer, Y., Fan, G.-H., & Lohse, M. J. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12297-3 · Cited by 61
Backstrom, J. R., Price, R. D., Reasoner, D. T., & Sanders‐Bush, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000922200 · Cited by 60
Organisation of G-protein-coupled receptor signalling complexes by scaffolding proteins
Kreienkamp, H. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00203-5 · Cited by 59
Zhou, Y.-Y., Yang, D., Zhu, W., Zhang, S.-J., Wang, D.-J., Rohrer, D. K., Devic, E., Kobilka, B. K., Lakatta, E. G., Cheng, H., et al. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.5.887 · Cited by 55
The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance
Zimanyi, I. A., & Pelleymounter, M. A. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391234 · Cited by 53
Ai, L.-S., & Liao, F. (2002) · Biochemistry · doi:10.1021/bi025855y · Cited by 51
Vanhauwe, J. F. M., Fraeyman, N., Francken, B. J. B., Luyten, W. H. M. L., & Leysen, J. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34980-8 · Cited by 47
Role of Central Melanocortin Signaling in Eating Disorders
Lu, X., PhD, & Rush, A. J. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4239 · Cited by 43
The Melanocortin System and its Role in Obesity and Cachexia
Goodfellow, V. S., & Saunders, J. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452212 · Cited by 40
Regulation of Yellow Pigment Formation in Mice: A Historical Perspective
Wolff, G. L. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00012.x · Cited by 34
Insight into the Mechanism of Dopamine D1-like Receptor Activation
Tumova, K., Iwasiow, R. M., & Tiberi, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208059200 · Cited by 26
The Function of Extracellular Cysteines in the Human Adrenomedullin Receptor
Kuwasako, K., Kitamura, K., Uemura, T., Nagoshi, Y., Kato, J., & Eto, T. (2003) · Hypertension Research · doi:10.1291/hypres.26.s25 · Cited by 19
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Mehlmann, L. M. (2005) · Reproduction · doi:10.1530/rep.1.00793 · Cited by 491
The evasive nature of drug efficacy: implications for drug discovery
Galandrin, S., Oligny-Longpré, G., & Bouvier, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.005 · Cited by 363
Galandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
Metadata
- Authors
- Milligan, G.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 64
- Issue
- 6
- Pages
- 1271-1276
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2131086952
- Cited by
- 252
- References
- 65
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.